The government announced Production Linked Incentive (PLI) scheme this month, this was in addition to the same scheme announced earlier this year. PLI scheme ...
This is a guest post by Saket Mehrotra. Number cruncher, avid reader, coffee connoisseur, book store hopper & Metallica fan. An active follower of Sensex ...
We come across a large number of interesting stocks in Capitalmind SNAP Outliers, our discovery tool for stocks with momentum. Here’s a look at Divi's ...
Today we cover the Form 483 issued by the US FDA to Dr. Reddy’s oncology formulation manufacturing facility at Duvvada at Visakhapatnam, Andhra Pradesh. ...
Today we cover the Form 483 issued by the US FDA to Cadila Healthcare’s formulations manufacturing plant at Baddi. On another note, the company is due ...
True to our promise of keeping a tab on the regulatory inspections of Indian Pharmaceutical companies, we are happy to get our hands on the Form 483 issued ...
True to our promise of keeping a tab on the regulatory inspections of Indian Pharmaceutical companies, we are happy to get our hands on the Form 483 issued ...
How do you make a first impression? Something like what the American President-elect Donald Trump did in his first press conference since being elected the ...
Here is our coverage of the Form 483 issued by the US FDA from the inspection of Divis Laboratories Unit-II located at Visakhapatnam. You can catch all our ...